Cargando…

Multifarious immunotherapeutic approaches to cure HIV-1 infection

Immunotherapy in the context of treated HIV-1 infection aims to improve immune responses to achieve better control of the virus. To date, multifaceted immunotherapeutic approaches have been shown to reduce immune activation and increase CD4 T-lymphocyte counts, further to the effects of antiretrovir...

Descripción completa

Detalles Bibliográficos
Autores principales: Imami, Nesrina, Herasimtschuk, Anna A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635699/
https://www.ncbi.nlm.nih.gov/pubmed/26048144
http://dx.doi.org/10.1080/21645515.2015.1021523
_version_ 1782399537375084544
author Imami, Nesrina
Herasimtschuk, Anna A
author_facet Imami, Nesrina
Herasimtschuk, Anna A
author_sort Imami, Nesrina
collection PubMed
description Immunotherapy in the context of treated HIV-1 infection aims to improve immune responses to achieve better control of the virus. To date, multifaceted immunotherapeutic approaches have been shown to reduce immune activation and increase CD4 T-lymphocyte counts, further to the effects of antiretroviral therapy alone, in addition to improving HIV-1-specific T-cell responses. While sterilizing cure of HIV-1 would involve elimination of all replication-competent virus, a functional cure in which the host has long-lasting control of viral replication may be more feasible. In this commentary, we discuss novel strategies aimed at targeting the latent viral reservoir with cure of HIV-1 infection being the ultimate goal, an achievement that would have considerable impact on worldwide HIV-1 infection.
format Online
Article
Text
id pubmed-4635699
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-46356992016-02-03 Multifarious immunotherapeutic approaches to cure HIV-1 infection Imami, Nesrina Herasimtschuk, Anna A Hum Vaccin Immunother Commentary Immunotherapy in the context of treated HIV-1 infection aims to improve immune responses to achieve better control of the virus. To date, multifaceted immunotherapeutic approaches have been shown to reduce immune activation and increase CD4 T-lymphocyte counts, further to the effects of antiretroviral therapy alone, in addition to improving HIV-1-specific T-cell responses. While sterilizing cure of HIV-1 would involve elimination of all replication-competent virus, a functional cure in which the host has long-lasting control of viral replication may be more feasible. In this commentary, we discuss novel strategies aimed at targeting the latent viral reservoir with cure of HIV-1 infection being the ultimate goal, an achievement that would have considerable impact on worldwide HIV-1 infection. Taylor & Francis 2015-06-05 /pmc/articles/PMC4635699/ /pubmed/26048144 http://dx.doi.org/10.1080/21645515.2015.1021523 Text en © 2015 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Commentary
Imami, Nesrina
Herasimtschuk, Anna A
Multifarious immunotherapeutic approaches to cure HIV-1 infection
title Multifarious immunotherapeutic approaches to cure HIV-1 infection
title_full Multifarious immunotherapeutic approaches to cure HIV-1 infection
title_fullStr Multifarious immunotherapeutic approaches to cure HIV-1 infection
title_full_unstemmed Multifarious immunotherapeutic approaches to cure HIV-1 infection
title_short Multifarious immunotherapeutic approaches to cure HIV-1 infection
title_sort multifarious immunotherapeutic approaches to cure hiv-1 infection
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4635699/
https://www.ncbi.nlm.nih.gov/pubmed/26048144
http://dx.doi.org/10.1080/21645515.2015.1021523
work_keys_str_mv AT imaminesrina multifariousimmunotherapeuticapproachestocurehiv1infection
AT herasimtschukannaa multifariousimmunotherapeuticapproachestocurehiv1infection